Wui-Jin Koh, MD
National Comprehensive Cancer Network

Lifen Cao, MD, PhD
University Hospitals Cleveland Medical Center, Case Western Reserve University

Peter G. Doukas, MD
Northwestern University Feinberg School of Medicine

Joshua W. Goyert, MS
University of Michigan Medical School

Ping Jiang, PhD
Peking University Third Hospital

Priyanka Reddy, MD
Case Western Reserve University Hospital: University Hospitals

Sri Harsha Tella, MBBS, FACP
Mayo Clinic Cancer Center

Ami Vyas, PhD, MS, MBA
University of Rhode Island

NCCN Continuing Education Disclosure Policy

It is the policy of NCCN that all planners, faculty, moderators, authors, reviewers and anyone involved in the planning and delivery of NCCN continuing education activities are expected to disclose ALL financial relationships they have had in the past 24 months with ineligible companies. The ACCME Standards for Integrity and Independence require that individuals who refuse to provide this information will be disqualified from involvement in the planning and implementation of accredited continuing education presented by NCCN. NCCN identifies, mitigates, and discloses to learners all relevant financial relationships.

In addition, all content has been reviewed to ensure education promotes safe, effective patient care and does not promote the products or services of an ineligible company. Content, including any presentation of therapeutic options, is fair, balanced, evidence-based, scientifically accurate, and free of commercial bias and marketing. 

Definitions

Ineligible Company: An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. 

Relevant Financial Relationships: Financial relationships of any dollar amount occurring within the past 24 months are defined as relevant if the educational content an individual can control is related to the business lines or products of an ineligible company. There is no minimum financial threshold. We ask for disclosure of ALL financial relationships with ineligible companies, regardless of the amount and regardless of the potential relevance of each relationship to the education.

Faculty Disclaimers

All faculty for this continuing education activity are competent in the subject matter and qualified by experience, training, and/or preparation for the tasks and methods of delivery.

Faculty presentations may include discussion of off-label use. Faculty will disclose that the use in question is not currently approved by the FDA per the product labeling or marketing.

Faculty Disclosures

Primary Authors and Co-Authors: Oral Presentations from the NCCN Poster Session

The faculty listed below have no relevant financial relationship(s) with ineligible companies to disclose.

Steven Alberts, MD
Amanda L. Amin, MD
Hannah N. Bell, BS
Mitesh Borad, MD
Jennifer Boyer, APRN 
Lifen Cao, MD, PhD
Xiuwen Deng, PhD
Peter G. Doukas, MD
Martin Fernandez-Zapico, MD
Nathan Foster, MS
Briant Fruth
Joshua W. Goyert, MS
Mindy Hartgers, APRN, CNP, MS
Tara L. Hogenson, MS
Ping Jiang, PhD
Weijuan Jiang, PhD
Stephen J. Kogut, PhD, MBA
James Martin, MD
Megan E. Miller, MD
Henry Pitot, MD
Gavino Puggioni, PhD, MS
Ang Qu, PhD
Priyanka Reddy, MD
Yatrik M. Shah, PhD
Robert Shenk, MD
Frederique St. Pierre, MD
Nickolas Stabellini, MS
Sri Harsha Tella, MBBS, FACP
Nguyen Tran, MD
Junjie Wang, PhD
Leslie Washburn, MPAS, PA-C
Jaclynn Wessling, MD

The faculty listed below have the following relevant financial relationship(s) with ineligible companies to disclose. All of the relevant financial relationships listed for these individuals have been mitigated.

Zhaohui Jin, MD
Daiichi- Sankyo Co.: Scientific Advisor
Eli Lilly and Company: Scientific Advisor
GlaxoSmithKline: Scientific Advisor
Novartis Pharmaceuticals Corporation: Scientific Advisor 
QED Therapeutics, Inc.: Scientific Advisor 

Minetta Liu, MD
Eisai Inc.: Grant/Research Support 
Exact Sciences: Grant/Research Support
Genentech, Inc.: Grant/Research Support
Genomic Health, Inc.: Grant/Research Support
GRAIL: Grant/Research Support
Menarini Silicon Biosystems: Grant/Research Support
Merck & Co., Inc.: Grant/Research Support
Novartis Pharmaceuticals Corporation: Grant/Research Support
Seattle Genetics, Inc.: Grant/Research Support
TESARO, Inc.: Grant/Research Support

Shuo Ma, MD, PhD
AbbVie, Inc.: Grant/Research Support; Scientific Advisor
AstraZeneca Pharmaceuticals LP: Consulting Fee; Grant/Research Support; Product/Speakers Bureau 
BeiGene: Consulting Fee; Grant/Research Support; Product/Speakers Bureau
Janssen Pharmaceutica Products, LP: Consulting Fee; Grant/Research Support; Product/Speakers Bureau
Juno Therapeutics, Inc.: Grant/Research Support
Loxo Oncology, Inc.: Grant/Research Support
Pharmacyclics: Grant/Research Support; Product/Speakers Bureau
TG Therapeutics, Inc.: Consulting Fee; Grant/Research Support 

Wen Wee Ma, MD
Actuate Therapeutics: Grant/Research Support 
Athenex, Inc.: Grant/Research Support
BioMed Valley Discoveries: Grant/Research Support
Bristol-Myers Squibb Company: Grant/Research Support
Cardiff Oncology: Grant/Research Support
Genentech, Inc.: Grant/Research Support
Jacobio Pharmaceuticals: Grant/Research Support 
Kodikaz Therapeutic Solutions: Equity Interest/Stock Options
Merus: Grant/Research Support
SunPharma Ltd: Grant/Research Support

Amit Mahipal, MD, MPH
AstraZeneca Pharmaceuticals LP: Honoraria
QED Therapeutics, Inc.: Honoraria 

Robert McWilliams, MD
Zentalis Pharmaceuticals: Equity Interest/Stock Options

Alberto J. Montero, MD, MBA
AstraZeneca Pharmaceuticals LP: Product/Speakers Bureau 
OncoSec Medical Incorporated.: Scientific Advisor 

Qian Shi, PhD
Boehringer Ingelheim GmbH: Scientific Advisor 
Bristol-Myers Squibb Company: Grant/Research Support 
Chugai Pharmaceutical Co., Ltd: Honoraria 
Genentech, Inc.: Grant/Research Support 
Johnson & Johnson: Grant/Research Support
Naveris: Grant/Research Support
Regeneron Pharmaceuticals, Inc.: Consulting Fee
Roche Laboratories, Inc.: Grant/Research Support 
Yiviva Inc.: Scientific Advisor 

Christopher W. Towe, MD
AstraZeneca Pharmaceuticals LP: Consulting Fee
AtriCure, Inc.: Consulting Fee 
Medtronic, Inc.: Scientific Advisor 
Zimmer Biomet: Consulting Fee; Grant/Research Support; Intellectual Property Rights 

Ami Vyas, PhD, MS, MBA
Merck & Co., Inc.: Grant/Research Support 

Moderator

The faculty listed below have no relevant financial relationship(s) with ineligible companies to disclose.

Wui-Jin Koh, MD

NCCN Staff Disclosures 

The planners listed below have the following relevant financial relationship(s) with ineligible companies to disclose. All of the relevant financial relationships listed for these individuals have been mitigated.

Crystal Denlinger, MD, FACP
Agios, Inc.: Grant/Research Support
Amgen Inc.: Grant/Research Support
Astellas Pharma US, Inc.: Scientific Advisor
AstraZeneca Pharmaceuticals LP: Grant/Research Support
BeiGene: Scientific Advisor; Grant/Research Support
Bristol-Myers Squibb Company: Scientific Advisor; Grant/Research Support
Eli Lilly and Company: Grant/Research Support
Exelixis Inc.: Scientific Advisor; Grant/Research Support
Genmab: Grant/Research Support
MacroGenics: Grant/Research Support
MedImmune Inc: Grant/Research Support
Merck & Co., Inc.: Scientific Advisor
sanofi-aventis U.S.: Grant/Research Support
Taiho Pharmaceutials Co., Ltd.: Scientific Advisor
Zymeworks: Scientific Advisor; Grant/Research Support

Samantha L. Tamburro, RN, BSN, CPON
Flatiron Health, Inc.: Salary

None of the other planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.